Defendant
1 case as defendant.
Olaplex Holdings, Inc., commonly known as Olaplex, is a foundational health and beauty company headquartered in New York, New York, with significant operations in Santa Barbara, California. Founded in 2014 by Dean Christal, Eric Pressly, and Craig Hawker, the company went public on Nasdaq (OLPX) in September 2021. As of May 2026, Olaplex had a market capitalization of approximately $1.37 billion to $1.38 billion. The company reported net sales of $423.0 million for fiscal year 2025 and employs approximately 278 individuals as of December 31, 2025.
Olaplex specializes in science-led haircare products, utilizing its patented "bond-building" technology, primarily involving Bis-Aminopropyl Diglycol Dimaleate, to repair and protect hair from various types of damage. Its product lines include shampoos, conditioners, treatments (such as the Nº.3 Hair Perfector and Nº.0 Intensive Bond Building Treatment), oils, and masks. These products are distributed globally through professional salons, specialty retailers like Sephora and Ulta Beauty, the company's own e-commerce platform, and third-party online marketplaces.
In terms of patent litigation, Olaplex Inc. operates as a defending entity, holding over 180 patents in its portfolio. The company has been involved in one tracked case as a defendant, "Unified Patents v. Olaplex Inc.", which is before the Patent Trial and Appeal Board (PTAB). This posture indicates an operating company actively defending its intellectual property against challenges rather than asserting patents as a plaintiff.
A significant development in 2026 is the pending acquisition of Olaplex Holdings, Inc. by Henkel AG & Co. KGaA, a German global conglomerate, for $1.4 billion. This transaction, approved by Olaplex's board and majority shareholder Advent International, is expected to close in the second half of 2026, after which Olaplex will no longer be publicly traded on Nasdaq and will become a subsidiary of Henkel. Historically, Olaplex has also been involved in other legal matters, including a trade secrets lawsuit against L'Oréal that was settled in 2021.
Unified Patents filed a Post-Grant Review (PGR) petition against Olaplex Inc., the current assignee of US12214225, at the Patent Trial and Appeal Board, but the petition was not instituted on the merits.